Dana Investment Advisors, Inc. Sarepta Therapeutics, Inc. Transaction History

Dana Investment Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 10, 2020	SELL	$127.12 - $172.34 $378,054 - $512,539	-2,974 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$93.0 - $171.7 $276,582 - $510,635	2,974 New	2,974 $477,000
Q1 2020 May 13, 2020	SELL	$82.38 - $131.64 $207,103 - $330,942	-2,514 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$76.53 - $135.58 $48,366 - $85,686	-632 Reduced 20.09%	2,514 $324,000
Q3 2019 Nov 12, 2019	BUY	$72.81 - $156.91 $65,383 - $140,905	898 Added 39.95%	3,146 $237,000
Q2 2019 Aug 13, 2019	SELL	$112.21 - $151.95 $2.26 Million - $3.06 Million	-20,139 Reduced 89.96%	2,248 $342,000
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $2.39 Million - $3.4 Million	22,387 New	22,387 $2.67 Million

521

85.9M

1.55M

1.37M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $5.33B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Dana Investment Advisors, Inc. with notifications on news.